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REVIEW
TYPHOID FEVER AS CELLULAR MICROBIOLOGICAL MODEL
Dahir Ramos de ANDRADE & Dahir Ramos de ANDRADE JÚNIOR
SUMMARY
The knowledge about typhoid fever pathogenesis is growing in the last years, mainly about the cellular and molecular phenomena
that are responsible by clinical manifestations of this disease. In this article are discussed several recent discoveries, as follows: a)
Bacterial type III protein secretion system; b) The five virulence genes of Salmonella spp. that encoding Sips (Salmonella invasion
protein) A, B, C, D and E, which are capable of induce apoptosis in macrophages; c) The function of Toll R2 and Toll R4 receptors
present in the macrophage surface (discovered in the Drosophila). The Toll family receptors are critical in the signalizing mediated by
LPS in macrophages in association with LBP and CD14; d) The lines of immune defense between intestinal lumen and internal
organs; e) The fundamental role of the endothelial cells in the inflammatory deviation from bloodstream into infected tissues by
bacteria. In addition to above subjects, the authors comment the correlation between the clinical features of typhoid fever and the
cellular and molecular phenomena of this disease, as well as the therapeutic consequences of this knowledge.
KEYWORDS: Typhoid Fever; Salmonella enterica serovar Typhi; Cellular Microbiology; Bacteria-Cell interaction.
Classically, typhoid fever is considered a disease of multiple stages:
1) the first week is characterized by progressive elevation of the
temperature, followed by bacteremia; 2) the second week comes with
rose spots in the skin, abdominal pain, and splenomegaly; 3) the third
week marks a more intensive intestinal inflammatory process, particularly
in the Peyer’s patches, and complications may develop as digestive
bleeding and intestinal perforation. The patients may have clinical
recovery afterwards. However, some patients may die after a progressive
clinical worsening not responsive to the treatment with antibiotics against
Salmonella enterica subsp. enterica serovar Typhi (S.Typhi).
The knowledge about typhoid fever pathogenesis has grown in the
last years, mainly about the cellular and molecular phenomena that are
responsible by clinical manifestations of this disease. In this article are
discussed some recent discoveries about Salmonella spp. as follows: a)
bacterial type III protein secretion system (TTSS); b) the five virulence
genes (A, B, C, D and E) of Salmonella spp. that encoding Sips
(Salmonella Invasion Proteins); c) Toll R2 and Toll R4 receptors present
in the macrophage surface, that are critical in the signalizing mediated
by LPS in macrophages; d) the lines of immune defense between intestinal
lumen and internal organs; e) the fundamental role of the endothelial
cells in the inflammatory deviation from bloodstream into infected tissues
by bacteria. With the new discoveries about typhoid fever pathogenesis,
we consider this disease as an authentic cellular microbiological model
of study.
The knowledge about typhoid fever raises some doubts. The use of
microbicide therapeutic should be evaluated in relation to the risks of
disease worsening because of elevation of the lipopolysaccharide (LPS)
molecules. These molecules are called as LPS/endotoxin, and they are
responsible for the mononuclear cell activation that release cytokines as
TNF-alpha, IL-1, IL-6, IFN-gamma, etc.
LPS is considered a powerful agent for the inflammatory cells
activation, and it acts through CD14, Toll R2 and Toll R4 receptors.
Through them, LPS transmits signals to intracellular protein chain known
as p21 activated kinase (PAK) studied in Salmonella enterica serovar
Typhimurium (S.Typhimurium)10. Other proteins activated by S.
Typhimurium are the Rho-GTPases that are capable to stimulate the
membrane “ruffling” (the rearrangement of cellular membrane), through
which Salmonella spp. entry into the cells. At this moment, the
rearrangement of actin cytoskeleton and the nuclear responses also
happens.
The contact of cytosol with proteins secreted by invasive bacteria
(S.Typhi, S.Typhimurium, S. Cholerae-suis, etc.) is made through protein
channels named type III secretion system (TTSS) that translocate bacterial
proteins inside of the cells. The genetic acquisition of TTSS was a major
evolutionary leap for gram-negative bacterial pathogens. TTSS allow
animal and plant pathogens to inject their own proteins, termed effectors,
directly into host cells and that modulate specific host cellular functions27.
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These ‘molecular syringes’ and their secreted effectors are essential
virulence determinants. The protein Sop E is substratum of this secretion
system, and it stimulates the cytoskeleton reorganization followed by
the JNK protein chain activation, which is dependent of Rac-1 and CDC
4219. MAP kinases’s role in the nuclear responses and cytokines
production induced by inflammatory cells and by cultured intestinal cells
were discussed in another study22. These recent publications about
mechanisms of Salmonella spp. action highlightes the knowledge of the
evolution of molecular and cellular phenomena in the human typhoid
fever. These phenomena are the base of disease’s symptoms and clinical
manifestations.
TYPHOID FEVER PATHOGENESIS
1) Intestinal mucosal Immunity (first line of defense): The
infectious dose of S.Typhi in volunteers varies between 1000 and 1
million organisms25. This bacterium must survive the gastric acid barrier
to reach the small intestine, and a low gastric pH is an important defense
mechanism. In the small intestine, S. Typhi moves across the intestinal
epithelial cell (CEI) and reach the M cells, thus penetrating in the Peyer’s
patches. The M cells, specialized epithelial cells overlying Peyer’s
patches, are probably originated from CEI and small pockets in the
mucosal surface characterize them. After contact with M cells, the
infectious agents are rapidly internalized and they reach firstly a group
of antigen-presenting cells (APCs), being partially phagocytized and
neutralized. Some bacteria escape of this barrier, and they reach the well-
developed lymphoid follicles (Peyer’s patches), formed mainly by
mononuclear cells as T lymphocytes, as well as dendritic cells. Dendritic
cells present the bacterial antigens and they provoke T and B lymphocytes
activation.
2) Dissemination from intestinal mucosa’s lamina propria:
Starting from lamina propria, T and B lymphocytes activated come out
for the lymphatic nodules. They will reach the mesenteric veins through
lamina propria blood vessels, and then they arrive to liver and spleen. In
these organs, the bacteria are destroyed mainly after phagocytosis by
macrophage system. However, Salmonella spp. organisms are able to
survive and multiply within the mononuclear phagocytic cells26.
At a critical point determined by the number of bacteria, the bacterial
virulence and the host immune response, bacteria are released from their
sequestered intracellular habitat into the bloodstream. This bacteremic
phase of disease is characterized by widely dissemination of the
organisms. The most common sites of secondary infection are the liver,
spleen, bone marrow, gallbladder and Peyer’s patches in the terminal
ileum. In the liver, S. Typhi provokes Kupffer cells activation. Kupffer
cells have high microbicide power, and they neutralize the bacteria with
oxidative enzymes (via oxygen free radicals, nitric oxide, etc.), as well
as enzymes active in acid pH. These cells constitute the most effective
barrier to invasive bacteria as S. Typhi and S. Typhimurium. The survivor
bacteria reach and invade hepatocytes, and they will cause high cellular
death rate, mainly apoptosis3. The apoptosis occurs through activated
kinases that phosphorylase protein responsible for signs transmission to
the nucleus. In our laboratory, we could verify that the rat hepatocytes
produce TNF-alpha in a time-dependent and progressive form when
invaded by S. Typhimurium4,5. This phenomenon is very important, since
the TNF-alpha is capable to amplify the local inflammatory response
and to induce the hepatocyte death by apoptosis.
3) Main host immune defense: The main host defense against
Salmonella spp. occurs through the neutrophils at first, followed by
mononuclear cells. These inflammatory cells produce cytokines as Tumor
Necrosis Factor alpha (TNF-alpha), Interferon-gamma (IFN-gamma),
IL-1, IL-2, IL-6 and IL-8. The Kupffer cell is the main TNF-alpha
producer in the liver. Several studies have shown that epithelial cells
play a central role in coordinate the intestinal inflammatory response to
intestinal pathogens. The interaction of Salmonella spp. with epithelial
cells leads to the generation of a great number of biochemical signals by
these cells. These include the basolateral release of chemokines (including
IL-8) and apical secretion of “pathogen - elicited epithelial
chemoattractant” (PEEC)13,33. These substances are partially responsible
for guide the recruitment and traffic of PMNs across CEIs. In recent
study was showed that S. Typhimurium induces IL-8 secretion by
intestinal epithelia through increase in intracellular calcium. This
phenomenon was NF-kappaB dependent18. A functional TTSS is required
for the induction of PMN transmigration. Furthermore, protein synthesis
in both bacteria and epithelial cells is also required for this activity.
Invasion of Salmonella spp. into epithelial cells is insufficient for
transepithelial signaling to PMNs, and PMN migration occurs even when
Salmonella spp. invasion is blocked17.
The “inflammatory deviation” that happens when blood leukocyte
migrates across endothelial cells into hepatic and spleen tissues is another
important event. This phenomenon occurs through the action of adhesion
molecules named integrins (chain αβ) in inflammatory cells and selectins
in endothelial cells (E and P). Afterward, selectins are substituted by
ICAMs and VCAMs proteins (whose partner in inflammatory cells is
VLA4 or α4β1 integrin). The inflammatory microenvironment is
completed by chemokines that are capable to stimulate leukocyte motility
(chemokinesis) and directed movement (chemotaxis) of neutrophils and
mononuclear cells. Chemokines bind to CC and CXC receptors in the
surface of inflammatory cells. The chemokines help the blood leukocytes
migration straight for host cells infected by bacteria.
TNF-alpha is a cytokine produced by macrophages and other
mononuclear cells, and it has the greater antibacterial agent against
Salmonella spp. TNF-alpha in association with IFN-gamma, IL-2 and
other cytokines, will be responsible for the neutralization of this invasive
bacteria, besides the macrophage phagocytosis.
4) Apoptosis and the human Toll receptor activated in typhoid
fever: Typhoid fever disease is an important example of severe sepsis,
because it presents enormous amount of cellular death (necroapoptosis)
besides severe toxemia32. In this way, there are newest discoveries about
the Toll R2 and Toll R4 receptors studied in Drosophila.
The innate immune system uses Toll family receptors to sign microbes
presence and to start host defense. Bacterial lipoprotein (BLP) expressed
in all bacteria species are potent activators of “Toll-like receptor 2” (Toll
R2). The innate immune system includes macrophages and natural killer
(NK) cells that act directly on pathogens through cytokines and other
stimulatory molecules, which activate the adaptive immune responses
(cellular and molecular) through T and B lymphocytes35. The innate
immune system (first line of defense) identifies the pathogens by standard
recognition receptors, which attach to microbial macromolecules. In this
way, macrophage mannose receptors attach to structures with repeats of
polimannose. CD14 receptor, described some time ago, was considered
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as fundamental to recognize LPS/endotoxin in the surface of gram-
negative bacteria like Salmonella spp. before the discovery of the Toll
R2 receptor. The difference between CD14 and Toll R2 is that the former
are a “GPI” (glycosyl-phosphatidylinositol) receptor, that does not cross
the cellular membrane, and does not transmit signs for cytoplasm or
activate protein chains of macrophages23,35. In contrast, Toll R2 molecule
cross the cellular membrane, and transmits signs for the intracellular
protein chains. The activation of these protein pathways will spread to
transcriptional factor NF-kB that will migrate to cellular nucleus starting
from cytoplasm. NF-kB recognizes and liberates genes encoding the
adhesion molecules, TNF- alpha and another Th1 cytokines (IFN-gamma,
IL-2, etc.). The patients with failure of immune response to combat the
infection by macrophage activation may evolve to septic shock37.
The pathogens have molecular antigens that are recognized by
receptors as: LPS of gram-negative bacteria, glycolipid of mycobacteria,
lipoteichoic acid of Gram-positive bacteria, mannans of yeast, RNAs of
virus and others28,34.
Two LPS binding protein, BPI (bactericide permeability increasing
protein) and LBP (lipopolysaccharide binding protein) have fundamental
importance, because their connection with LPS results in distinct effects.
BPI (55 kD) has an antimicrobial role and it is present in neutrophils
with selective toxicity against gram-negative bacteria. This protein is
more effective when acts on neutrophils phagocytosis in synergism with
defensins (intestinal mucosa’s antimicrobial). LBP increases the
sensitivity to LPS allowing that effector cells are activated by
subpicomolar LPS concentrations. LBP recognizes Lipid A, that is the
half biologically active of the endotoxin molecule42,43. LBP also carry
out an important role in the bacterial clearance of peripheral blood through
CD14.
Recently, some studies indicate that Toll family receptors (TLRs)
are critical in the signalizing mediated by LPS, in association with LBP
and CD1423. The identification of a Toll human receptor homologous
(well known in Drosophila) named as hTLR4 (Toll-like human receptor
4), was a great discovery in knowledge on the complex binding receptor
with LPS34.
Nowadays six members of the “TLRs” family are known, and two
of them TLR2 and TLR4 were associated with LPS signalizing. However,
only TLR4 has been considered a LPS signalizing in humans8,21,41.
The hTLR4 protein has a repetitive sequence rich in leucine in its
extracellular domain that interacts with complex CD14 - LPS. TLR4
and other TLRs have a TIR cytoplasmic receptor (Toll-IL-1 receptor)1,2,39
in homologous domain to IL-1 receptor (IL-1R). This domain
communicates with an adapting protein My D88 (myeloid differentiation
factor 88) that interacts with TLR4 starting cell signalizing as follows:
IL-1R associated kinase (IRAK-1), TNF-alpha receptor (TNFR)
associated factor 6 (Traf-6) and NF-kB inducing kinase (NIK). The
kinases IRAK-1 and NIK phosphorylase inactive complex in the
cytoplasm named IkBs (IKKα and IKKβ), causing its degradation
through ubiquination-proteasome. This reaction releases the NF-kB/REL
dimer, and NF-kB migrates for nucleus when immunomodulatory genes
will be activated. In consequence, there is synthesis of cytokines, adhesion
molecules (ICAMs), stress proteins (HSPs), and activation of inhibitor
of apoptosis genes (IAPs). TLR2 transmits a proapoptotic sign via death
receptors and FADD protein (Fan-associated death domain). FADD
through death domain contacts homologous area in caspase-8 prodomain,
that cleaves effective caspases 3 and 7 and activate the apoptosis
program1,2. This final connection, bind TLR2 to cell apoptosis machine2.
5) Protein secretion mechanisms and other virulence mechanisms
of Salmonella: Bacteria as Salmonella spp.6,38 have type III secretion
system that to permit for they inject bacterial proteins in several host
cells, such as: CEIs, hepatocytes, endothelial cells and inflammatory
cells (neutrophils, monocytes-macrophages, T and B lymphocytes etc.)20.
Recent progresses in cellular microbiology15 have highlight the role
of type III secretion system as a protein secretion system highly
specialized found in gram-negative pathogens. As mentioned above, this
system transfers proteins from bacterial cytoplasm into the host cell
cytoplasm, with purpose of interfere in the host cellular function.
TTSS includes more than 20 proteins, and it is considered the most
complex bacterial protein secretion system associated with the pathogen
virulence. The structural components of TTSS can be divided in two
groups. One group consists of outer membrane proteins (including one
similar to secretin family), and the other group has several integral
membrane proteins (similar to flagellar export apparatus). Supramolecular
structure associated with TTSS of S. Typhimurium was visualized by
electronic microscopy. This structure consists of a needle complex, spans
both the inner and outer membranes of bacterial envelope. The needle
complex has a long hollow structure about 120 nm long and it is
composed of two domains. The first is a needlelike portion projecting
outward from the bacteria surface and the second portion has a cylindrical
base that anchors the structure to inner and outer membranes.
The biochemical analysis revealed that the needle complex is
composed of three proteins: InvG (a member of secretin family), PrgH
and PrgK (lipoproteins). TTSS is an ATP – dependent system. S.
Typhimurium injects in host cells a set of effectors proteins inducing
actin cytoskeleton rearrangements, membrane ruffling and macro-
pinocytosis that finish in bacterial invasion. The effectors proteins include
an exchange factor for Rho GTPases (Sop E), an inositol phosphate
phosphatase (Sop B), and an actin-binding protein (Sip A)44. Sop E acts
as an exchange factor for a subset of Rho GTPases, including CDC42
and Rac. SopE and possibly other Sops induce enterocyte membrane
ruffling promoting bacterial cellular invasion. Sop B modulates the actin
cytoskeleton through its inositol phosphate phosphatase activity, which
generates a broad range of inositol phospholipids and inositol phosphates.
The intracellular SopB protein affects inositol phosphate signalling
events. One such event is a transient increase in concentration of Ins
[1,4,5,6] P
4
, which can antagonize the closure of chloride channels,
influencing net electrolyte transport and fluid secretion. Sip A inhibits
the F-actin depolymerization after its binding to actin. Pathogen-induced
remodeling of the host cell actin drives internalization of invasive
Salmonella by non-phagocytic CEIs.
Two Salmonella actin-binding proteins are involved in bacterial
internalization: SipC that is essential for the internalization process, and
SipA that enhances its efficiency44.
S. Typhi and other Salmonella serovars have two phenotypes
associated with TTSS: one is involved in bacterial invasion to
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nonphagocytic cells, as well as induction of apoptosis in macrophages
through Sip B21; the other is required for bacterial survival inside
macrophages and for systemic infection.
Nowadays, a new group of virulence genes has been identified in
Salmonella, named Sips (Salmonella invasion proteins) containing five
genes: Sip A, Sip B, Sip C, Sip D and Sip E. Sip B gene encodes Sip B
protein that is involved in proteins translocation via TTSS, and it has
potential to induce apoptosis in macrophages through caspase-1
activation. This fact was showed through Sip B injection in macrophages,
which caused apoptosis by caspase-1 activation36. In Salmonella,
however, Sip B role inducing apoptosis and concomitant release of IL-1
beta (proinflammatory cytokine) is unclear (in contrast to Shigella).
Another peculiar aspect of Salmonella was showed by ECKMANN
et al.14. In this study, the CEIs invaded by Salmonella increased the
cytokines mRNAs expression as G-CSF, IL-8, MIP-2α, and transcription
factors as IRF-1 and NF-kB, as well as HLA class I. These discoveries
allow understanding better the bacteria – cell interaction.
Recently, HOOPER & GORDON24 showed that serovars of avirulent
Salmonella spp. are capable to inhibit cytokines production by CEIs.
This phenomenon involves IkB that blocks the NF-kB migration to
nucleus. The avirulent Salmonella inhibited the IkB ubiquination and
its degradation by proteasome 26S. Thus, genes transcription managed
by NF-kB was blocked. These genes encode proinflammatory mediators
as cytokines, chemokines and adhesion molecules.
The knowledge of bacterial pathogenesis was increased by virulence
genes discovery, which are acquired by pathogens and introduced in
bacterial DNA. Nowadays, these genes are known as “pathogenicity
islands” (PAIs) involving a great genetic area with more than 100
kilobases (kb). Five PAIs have been identified in the Salmonella species.
Two of these PAIs, Salmonella pathogenicity island (SPI)-1 and SPI-2,
encode TTSS, which are essential virulence determinants. SPI-1 and
SPI-2 are expressed under distinct environmental conditions: SPI-1 is
induced after initial contact with the host cell, whereas SPI-2 is induced
intracellular. In spite of bacterial diversification, gene transfer capacity
to become a microorganism of success is variable. In Salmonella are
necessary five pathogenicity islands for disease evolution40. In contrast,
in Escherichia coli one pathogenicity island is enough to increase
bacterial virulence.
6) Clinical manifestations of typhoid fever and their
pathogenesis: S. Typhimurium and other serovars causes gastroenteritis
with intestinal acute inflammation of limited duration in people with
normal immune defense. S. Typhi is responsible for typhoid fever in
humans, a disease with high clinical toxicity and possible evolution to
death6,38.
The symptoms and clinical signs in patients with typhoid fever are
related to cellular microbiological phenomena12. The bacterial invasion
of several host cells and the inflammatory response (neutrophils,
monocytes-macrophages, T and B lymphocytes) with high cytokines
production are important elements causing the clinical manifestations.
Cytokines produced (IL-1, IL-6, TNF-alpha, Interferons - α, β and γ)
are also responsible for fever emergence, with four weeks length in the
typhoid fever without treatment.
The potent inflammatory reaction against Salmonella spp. has the
inconvenience of to provoke the host cells death, as well as the apoptosis
of both inflammatory and epithelial cells. This phenomena result in the
appearance of several clinical signs as fever, jaundice (due to hepatocytes
death and cholangiocytes activation), and increase of enzymes AST, ALT,
γ-glutamyltranspeptidase, alkaline phosphatase, etc. The amino-
transferases rise in moderate levels (100 to 300 UI/l), and γ-
glutamyltranspeptidase and alkaline phosphatase (markers of activated
cholangiocytes) may reach 50 to 300 UI/l. These latter two enzymes are
situated in the biliary cell membrane.
The increase of cytokines in the peripheral blood will cause fever
after incubation period of 5 to 21 days. Initially the fever is low grade,
but it rises progressively, and by the second week it is often high and
sustained (39 °C to 40 °C). The fever occurs in more than 80% of patients
in both sexes31, with men predominance. The classic disease description
includes bacteremia and fever during the first week, as well as nonspecific
symptoms as chills, headache, anorexia, sore throat, myalgia, psychosis
and mental confusion in 5 to 10% (typhoid state). A coated tongue,
tender abdomen, hepatomegaly, and splenomegaly are common. In the
second week, a few rose spots, blanching erythematous maculopapular
lesions, approximately 2 to 4 mm in diameter appear in 5 to 30 percent
of cases. They usually occur on the abdomen and chest and more rarely
on the back, arms, and legs. A relative bradycardia in relation to fever,
intestinal constipation, and diarrhea in smaller number of patients (mainly
in young children and adults with HIV infection) may occur. This classic
pattern of typhoid fever has been modified by earlier diagnosis and more
effective treatment. In spite of these advances, some patients still may
present the clinical manifestations of first and second weeks. In the cases
without treatment or correct diagnosis, the typhoid fever prolongs to
third week. In this period, the inflammatory lesions are intense in Peyer’s
patches and intestinal lamina propria (with abundant monocytes,
macrophages and lymphocytes). There is lymphoid hyperplasia in the
ileocecal area followed by ulceration and necrosis (cellular death), with
subsequent gastrointestinal bleeding or intestinal perforation.
Complications occur in 10 to 15 percent of patients and they can evolve
to death, in general after the third week of disease. Symptoms as anorexia,
weigh loss, intense weakness, mental confusion, and others, may occur
in typhoid fever especially when there is a delay in the diagnosis and
treatment.
Relapse of disease occurs in 5 to 10 percent of patients, usually two
to three weeks after the fever resolution. The high fever and progressive
abdominal pain appear again. This phenomenon may be owing to
secondary bacteremia from normal enteric flora due to Peyer’s patches
inflammation. The fever declines in the 4th week of disease in 90% of
survivors, without antibiotic therapy. However, weakness and weight
loss may persist during many months. Pyogenic meningitis, acute
cholangitis and mural endocarditis are rare manifestations of typhoid
fever. The immune response against S. Typhi has probably similar
influence in all these clinical conditions.
The true “sepsis”, which constitutes the severe typhoid fever disease,
is caused by LPS/endotoxin molecules that are abundant in the surface
of Enterobacteriaceae as Salmonella spp., Escherichia coli, etc. These
molecules are capable to activate the macrophages, through cell surface
receptors known like CD14, Toll R2 and Toll R4 (in humans) as
mentioned above. The inflammatory response of Th1-dominant type is
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destructive for host cells and for bacteria. Th1 response attenuates
progressively, and this coincides with increase of Th2- immune response.
Th2 cells produce IL-4, IL-10, IL-13, TGF-β, that causes a powerful
protecting effect in the host cells (hepatocytes, CEIs, inflammatory cells
etc.), through the partial inhibition of cytokines associated with Th1
cells. The predominance of Th1 immune response can be detected by
the immunohistochemistry technique with specific antibodies. Another
available technique is bioassay or immunoassay that detect cytokines
(as IFN-gamma) in peripheral mononuclear cells by the flow cytometer
or “ELISPOT”. The ELISPOT technique is of recent discovery and it is
capable to evaluate cellular frequencies in a quantitative way, through
identification of cells producing IFN-gamma that characterize Th1
immune response.
The deficiency in inhibit the proinflammatory cytokines TNF-alpha,
IFN-gamma, IL-2, etc., will result in cellular destruction predominance
in relation to cellular protection. This phenomenon provokes serious
tissue lesions, as intestinal perforation and hemorrhage. The patient’s
clinical condition is worse by these complications, and surgery or effective
hemostasia is necessary. At this moment, the patients have profound
weakness (due to high inflammatory reaction), high fever, weight loss
and other clinical manifestations. The ability of clinicians and surgeons
to resolve these problems has been responsible for the patients’ survival.
The gastrointestinal bleeding should be attributed to endothelial cells
activation through the increase of inflammatory cytokines and circulating
LPS/endotoxin, mainly in the intestines. This result in high rate of
endothelial cell death, and erosion of a necrotic tissue through the enteric
vessel wall. The vessel basal membrane rich in collagen is exposed
allowing the adherence of activated platelets. In addition, endothelial
cells with the participation of pro and anticoagulation systems also
activate the coagulation cascade. This microenvironment will be
responsible for the bleeding and CEI death, ulcerated lesions and
intestinal (usually ileal) perforation.
B lymphocytes are found in the central area of lymphoid follicles,
and migrate across vascular walls together with T lymphocytes. Some
lymphocytes are retained in the mesenteric lymph nodes, and they will
become plasma cells in the return to intestinal mucosa’s lamina propria.
At this moment, these cells are capable to produce IgG and IgM
immunoglobulins, as well as secretory IgA that is considered the first
line of intestinal defense. The final molecular junction of dimeric IgA
occurs within intestinal lamina propria. In this site, IgA receives a
protecting component produced by CEIs and remains resistant to digestive
enzymes. Afterwards, IgA is secreted for intestinal lumen by paracellular
via, covering the mucosa surface. Together with other protectors elements
of intestinal mucosa as intestinal flora, local antimicrobial, etc., the
secretory IgA constitutes the main element of the intestinal humoral
defense.
KEUTER et al.29 described the patterns of proinflammatory cytokines
in 44 patients with typhoid fever, through ELISA or RIA. The circulating
cytokines levels in the acute phase of disease were as follows (± SD):
IL-1β = <140 pg/ml; FNT-α = 130 ± 50 pg/ml; IL-6 = 96 ± 131 pg/ml;
IL-8 = 278 ± 293 pg/ml. The authors also showed that circulating
cytokines inhibitors were elevated in the acute clinical phase: IL-1 RA
(IL-1 receptor antagonist) = 2304 ± 1427 pg/ml; soluble TNF-alpha
receptors 55 and 75 = 4973 ± 2644 pg/ml and 22,865 ± 15,143 pg/ml,
respectively. In the convalescence, there was progressive decrease of
cytokines in the disease recovery. Probably, the presence of cytokines
inhibitors were necessary to counterbalance the high values of
proinflammatory cytokines. The same authors studied the influence of
blood peripheral 14 kDa group II phospholipase A2 (PLA2) in 12 patients
with typhoid fever, after admission and after recovery30. On admission,
PLA2 levels were high (1444 ± 1560 ng/ml), and decrease gradually to
55 ± 48 ng/ml at 14th day. Patient with complicated typhoid fever had
significantly higher PLA2 levels on admission (2520 ± 48 ng/ml). The
authors suggest that PLA2 may be a mediator of seriousness in prolonged
inflammatory diseases such as typhoid fever30.
The extensive knowledge of typhoid fever’s molecular and cellular
pathogenesis, allow to all of us better understanding of its clinical phases,
and more rational approach of the patient’s clinical manifestations. In
the future, we will be able to decrease the intensity of inflammatory
phenomena, through therapeutic maneuvers intending to disable
inflammatory cells (with cytokines decrease), as well as to inhibit the
cellular death (hepatocytes, inflammatory cells, etc.) related to Salmonella
spp. invasion.
7) Therapeutic cconsequences of typhoid fever pathogenesis: The
recent concepts about typhoid fever pathogenesis described above may
influence the therapeutical approach of this disease. In this way, the
glucocorticoids should be used in association with antibiotics in the adults
and children with severe typhoid fever characterized by high fever,
delirium, obtundation, coma or shock.
Recently, a study performed in Jakarta9 showed that patients with
severe typhoid fever treated with chloramphenicol and dexamethasone
have lower mortality as compared to chloramphenicol group. The patients
receiving dexamethasone had significant decrease of mortality from 56%
to 10%. In spite of the doubts about this study model, dexamethasone
should be considered for typhoid fever treatment in cases with mental
alterations or shock. However, glucocorticoid administration should be
avoided besides 48 hours, because the increased risk of disease relapses11.
Despite of the study mentioned above, the physicians should have
caution with the use of glucocorticoids associated with antibiotics in
cases of severe typhoid fever, due to the recent knowledge about the
mechanism of action of these antiinflammatory substances.
Glucocorticoids acts in macrophages and host cells (intestinal cells,
hepatocytes, etc.) through blockade of transcriptional factor NF-kB that
is responsible for cytokines release as TNF-alpha, IL-1, IL-6, IL-8, IFN-
gamma and others. NF-kB migrates to the nucleus of infected cells, where
it activates its target genes responsible for cytokines synthesis. Usually,
NF-kB is hold in inactive form by IkBα proteins in the glucocorticoids
presence, and it remains in the cytoplasm7. Some studies show that
glucocorticoids increase transcription of IkBα gene, and IkBα
concentrations go up within the cell. Other studies show that the
glucocorticoid receptor complex bind to NF-kB and blockade its binding
in DNA. TNF-alpha actuating through its cellular receptors TNFR-I or
TNFR-II is responsible for IkB phosphorylation and its degradation
through ubiquination/proteosome mechanisms, allowing the NF-kB
translocation for the nucleus. In addition to cytokines synthesis, NF-kB
also will be responsible for synthesis of vascular adhesion molecules
(ICAMs, Selectins and Integrins), and probably also stress proteins
synthesis, as well as apoptosis inhibitors (IAPs).
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Through the knowledge of molecular mechanisms of corticosteroid
action, these drugs should be used in a controlled way in order to reduce
inflammatory phenomena, without provoking its total inhibition. This
last extreme condition would facilitate the action of Salmonella spp.7.
RESUMO
Febre tifóide como modelo celular microbiológico
O conhecimento sobre a patogênese da febre tifóide vem crescendo
nos últimos anos, principalmente sobre os fenômenos celulares e
moleculares, responsáveis pelas manifestações clínicas desta doença.
Neste artigo são discutidas várias descobertas recentes, a saber: a) O
sistema bacteriano de secreção protéica tipo III; b) Os cinco genes de
virulência da Salmonella spp. que codificam os Sips (Salmonella invasion
protein) A, B, C, D e E, capazes de induzir apoptosis em macrófagos; c)
A função dos receptores Toll R2 e Toll R4 presentes na superfície de
macrófagos (descobertos na Drosophila). Os receptores da família Toll
são críticos na sinalização mediada por LPS nos macrófagos, em
associação com LBP e CD14; d) As linhas de defesa imune entre o lúmen
intestinal e os órgãos internos; e) O papel fundamental das células
endoteliais no desvio inflamatório, da corrente sanguínea para os tecidos
infectados pela bactéria. Além destes aspectos, os autores comentam a
correlação entre as características clínicas da febre tifóide e os fenômenos
celulares e moleculares da doença, bem como as conseqüências
terapêuticas deste conhecimento.
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